Results 141 to 150 of about 3,788,205 (194)

Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer. [PDF]

Front Oncol
Wang H, Li Y, Yang Z, Wang J, Qin K, Yu Y, Wang N, Jia J, Zhao W, Zhang F, Leitao MM, Meng R, Liu Y, Ding Y, Zhang Z.   +14 more
europepmc   +1 more source

Liquid Biopsy-Based Metabolomics in Epithelial Ovarian Cancer: Challenges, Methodological Advances and Translational Considerations. [PDF]

Diagnostics (Basel)
D'Agostino M, Laera L, Lanza M, Tolomeo D, Montopoli M, Storlazzi CT, Cormio G, Castegna A, Miglietta S.   +8 more
europepmc   +1 more source

Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model. [PDF]

Front Pharmacol
Lukanović D, Osredkar J, Škof E, Cviič D, Jerin A, Lešnik K, Matjašič M, Meglič L.   +7 more
europepmc   +1 more source

Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study. [PDF]

ESMO Real World Data Digit Oncol
Fagotti A, Frenel JS, Saint-Ghislain M, Lim JT, Calderón Boyle TA, Golembesky AK, Hogg C, Arnold K, Braicu EI.   +8 more
europepmc   +1 more source

Pyruvate carboxylase promotes SREBP1a-mediated lipid synthesis in epithelial ovarian cancer. [PDF]

Commun Biol
Huang X, Shi H, Shan W, Zhang J, Xu Q, Shang H.   +5 more
europepmc   +1 more source

Association between HER2 expression, genomic characteristics, and tumor immune microenvironment dynamics in epithelial ovarian cancer. [PDF]

Front Oncol
Salinaro J, De La Cruz P, Perati S, McAdams J, Buyungo S, Pearce J, Bojko A, Salaverria A, Singh K, DiSilvestro P, Mathews C, James NE.   +11 more
europepmc   +1 more source

The treatment of epithelial ovarian cancer [PDF]

Ca-A Cancer Journal for Clinicians, 1995
The treatment and long-term survival of patients with ovarian cancer varies by stage. At present, five-year survival for patients with early-stage disease ranges from 50 to 95 percent, while five-year survival for patients with advanced-stage disease is less than 25 percent.
William P McGuire, W P McGuire
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Epithelial Ovarian Cancer

Obstetrics and Gynecology Clinics of North America, 2012
The incidence of epithelial ovarian cancer in women aged 40 years and younger is 3-17%. The management of these women is challenging and requires balancing the need to treat epithelial ovarian cancer adequately and preserving reproductive potential. Fertility-sparing surgery, especially for early stage epithelial ovarian cancer, seems to be associated ...
Ahmed N, Al-Niaimi, Mostafa, Ahmed, Chase B, Petersen   +2 more
  +6 more sources